Erlotinib Terminated Phase 1 Trials for Dysplasia / Metaplasia / Pulmonary Precancerous Condition Prevention

IndicationsStatusPurposePhase
TerminatedPrevention1
clinicaltrials.gov IdentifierTitleDrugs
NCT01013831Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the Lung